# Arcturus Therapeutics Holdings Inc. (ARCT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ARCT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 3.57M | $ -50.75M | $ -39.35M | $ 22.93M | $ 171.81M |
| 2025 | $ 75.90M | $ -67.36M | $ -76.51M | $ 25.00M | $ 213.99M |
| 2024 | $ 145.46M | $ -85.08M | $ -63.48M | $ 28.55M | $ 240.98M |
| 2023 | $ 172.20M | $ -32.14M | $ -22.71M | $ 30.22M | $ 278.51M |
| 2022 | $ 230.12M | $ 10.44M | $ 27.11M | $ 94.76M | $ 270.31M |
| 2021 | $ 14.69M | $ -242.10M | $ -164.57M | $ 69.15M | $ 228.21M |
| 2020 | $ 12.15M | $ -91.91M | $ -56.82M | $ 20.75M | $ 396.55M |
| 2019 | $ 26.83M | $ -33.55M | $ -9.37M | $ 20.67M | $ 25.79M |
| 2018 | $ 20.80M | $ -28.77M | $ -29.37M | $ 9.91M | $ 13.64M |
| 2017 | $ 32.19M | $ -14.69M | $ -1.07M | $ 0 | $ 33.79M |
| 2016 | $ 0 | $ -33.85M | $ -26.57M | $ 130.0K | $ 47.23M |
| 2015 | $ 0 | $ -27.31M | $ -25.73M | $ 0 | $ 69.33M |
| 2014 | $ 0 | $ -46.39M | $ -40.14M | $ 0 | $ 19.94M |
| 2013 | $ 0 | $ -15.00M | $ -10.44M | $ 0 | $ 48.69M |
| 2012 | $ 0 | $ -1.47M | $ -1.31M | $ 662.0K | $ -567.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.13 |
| Liabilities / Eq | 0.31 |
| Current Ratio | 5.88 |

## Other views

- [Metrics](https://sponda.capital/en/ARCT.md)
- [Charts](https://sponda.capital/en/ARCT/charts.md)
- [Compare](https://sponda.capital/en/ARCT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.